Superstring Capital Management as of June 30, 2024
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 39 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 12.8 | $10M | 188k | 54.18 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 8.6 | $6.9M | 155k | 44.29 | |
| Terns Pharmaceuticals (TERN) | 8.2 | $6.5M | 957k | 6.81 | |
| Bridgebio Pharma (BBIO) | 7.0 | $5.6M | 220k | 25.33 | |
| 89bio (ETNB) | 6.9 | $5.5M | 680k | 8.01 | |
| Nkarta (NKTX) | 6.5 | $5.2M | 876k | 5.91 | |
| Zai Lab Adr (ZLAB) | 4.7 | $3.7M | 215k | 17.33 | |
| Keros Therapeutics (KROS) | 4.3 | $3.4M | 74k | 45.70 | |
| Arcellx Common Stock (ACLX) | 4.1 | $3.3M | 59k | 55.19 | |
| Arrowhead Pharmaceuticals (ARWR) | 3.6 | $2.9M | 111k | 25.99 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 3.2 | $2.6M | 57k | 45.25 | |
| Beigene Sponsored Adr (BGNE) | 2.2 | $1.8M | 13k | 142.67 | |
| Fate Therapeutics (FATE) | 2.1 | $1.6M | 497k | 3.28 | |
| Allogene Therapeutics (ALLO) | 2.0 | $1.6M | 690k | 2.33 | |
| Pyxis Oncology Common Stock (PYXS) | 2.0 | $1.6M | 484k | 3.31 | |
| Apogee Therapeutics (APGE) | 1.8 | $1.5M | 37k | 39.35 | |
| Cytomx Therapeutics (CTMX) | 1.8 | $1.4M | 1.2M | 1.22 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.6 | $1.2M | 64k | 19.21 | |
| Tourmaline Bio (TRML) | 1.5 | $1.2M | 95k | 12.86 | |
| Novocure Ord Shs (NVCR) | 1.4 | $1.1M | 67k | 17.13 | |
| Spyre Therapeutics Com New (SYRE) | 1.4 | $1.1M | 46k | 23.51 | |
| Cabaletta Bio (CABA) | 1.3 | $1.0M | 140k | 7.48 | |
| Tango Therapeutics (TNGX) | 1.2 | $992k | 116k | 8.58 | |
| Allakos (ALLK) | 1.2 | $941k | 941k | 1.00 | |
| Perspective Therapeutics Com New (CATX) | 1.1 | $874k | 88k | 9.97 | |
| Savara (SVRA) | 1.0 | $806k | 200k | 4.03 | |
| Biomea Fusion (BMEA) | 0.9 | $752k | 167k | 4.50 | |
| Kura Oncology (KURA) | 0.9 | $746k | 36k | 20.59 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.7 | $548k | 157k | 3.50 | |
| Atyr Pharma Com New (ATYR) | 0.6 | $488k | 313k | 1.56 | |
| Pepgen (PEPG) | 0.6 | $467k | 29k | 15.96 | |
| Karyopharm Therapeutics (KPTI) | 0.6 | $464k | 535k | 0.87 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.4 | $329k | 38k | 8.70 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.4 | $306k | 262k | 1.17 | |
| Mersana Therapeutics (MRSN) | 0.3 | $221k | 110k | 2.01 | |
| Lakeshore Biopharma Ordinary Shares (LSB) | 0.3 | $200k | 308k | 0.65 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $196k | 33k | 6.04 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.2 | $195k | 38k | 5.16 | |
| Spruce Biosciences (SPRB) | 0.1 | $40k | 78k | 0.52 |
